BECTON DICKINSON & CO — Director's Dealing 2022

May 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2022-05-06

Reporting Person: Hickey David (EVP & President, Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-06	Common Stock	S	475	$256	Disposed	3806	Direct

Footnotes

F1: Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person and and amounts previously deferred and reported on Table II.